HEG Ltd manufactures ultra-high power graphite electrodes used as a critical consumable in electric arc furnaces to melt scrap steel. It earns revenue by selling these electrodes to global steel producers, with a significant portion of its output exported to over 35 countries.
The company possesses a cost-based moat derived from operating the world's largest single-site manufacturing facility, which provides significant economies of scale compared to fragmented Western competitors. This is corroborated by the company maintaining 85-90% capacity utilization while global peers struggled at 60-65%, though volatile net margins and negative EPS growth over the cycle suggest the moat is narrow and sensitive to needle coke pricing.
Management has consistently reinvested in capacity expansion at its primary site to lower unit costs and is currently diversifying into the battery anode market. While the company maintains a strong net-cash balance sheet, the recent investment in GrafTech shares has resulted in significant mark-to-market losses, indicating a speculative element in non-core capital deployment.
The investment collapsed as the company's core graphite electrode business became a commodity trap while the diversification into battery anodes failed to scale. The speculative bet on GrafTech shares continued to bleed capital, proving management lacked discipline outside their primary silo. Meanwhile, the complex demerger and merger activities served as a distraction, allowing leaner competitors to erode the single-site cost advantage. As needle coke prices spiked and the company's negative EPS growth trend accelerated, the market finally re-rated the stock to reflect its true nature as a cyclical price-taker rather than a structural growth story.
RichFakir rates HEG Ltd's business quality as poor — 47/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, HEG Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on HEG Ltd is: Not rated. A poor business at an expensive price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of HEG Ltd's fair value is about ₹171 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →